USANA Health Sciences Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 66 out of 97 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 39.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of USANA Health Sciences Inc is 6.70, ranking 56 out of 97 in the Food & Tobacco industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 226.20M, representing a year-over-year increase of 5.89%, while its net profit experienced a year-over-year increase of 139.85%.
Key Metrics
The current valuation score of USANA Health Sciences Inc is 8.78, ranking 10 out of 97 in the Food & Tobacco industry. Its current P/E ratio is 29.15, which is 29.23% below the recent high of 37.67 and 59.70% above the recent low of 11.75.
No earnings forecast score is currently available for USANA Health Sciences Inc. The Food & Tobacco industry's average is 7.38. The average price target is 39.00, with a high of 39.00 and a low of 39.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of USANA Health Sciences Inc is 6.17, ranking 74 out of 97 in the Food & Tobacco industry. Currently, the stock price is trading between the resistance level at 19.80 and the support level at 15.38, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of USANA Health Sciences Inc is 5.00, ranking 43 out of 97 in the Food & Tobacco industry. The latest institutional shareholding proportion is 59.88%, representing a quarter-over-quarter decrease of 2.88%. The largest institutional shareholder is James Simons, holding a total of 1.15M shares, representing 6.22% of shares outstanding, with 6.67% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Tobacco domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of USANA Health Sciences Inc is 4.37, ranking 56 out of 97 in the Food & Tobacco industry. The company's beta value is 0.70. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. USANA Health Sciences Inc’s latest ESG disclosure leads the Food & Tobacco industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
